April 17, 2020
Family Members of SMA Patients Submit Petition for Early Zolgensma Listing Family members of patients with spinal muscular atrophy (SMA) are urging the Ministry of Health, Labor and Welfare (MHLW) to quickly list Zolgensma (onasemnogene abeparvovec), Novartis’ gene therapy for...read more